ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1111

Intra-Articular Mineralization on Knee CT Increases Risk of Knee Pain: The Multicenter Osteoarthritis Study

Tuhina Neogi1, John Lynch2, Mohamed Jarraya3, David Felson1, Na Wang1, James Torner4, Cora Lewis5, Michael Nevitt6 and Ali Guermazi1, 1Boston University School of Medicine, Boston, MA, 2UCSF, San Francisco, CA, 3Boston University School of Medicine, Boston, 4University of Iowa, Iowa City, IA, 5University of Alabama Birmingham, Birmingham, AL, 6University of California, San Francisco, San Francisco, CA

Meeting: ACR Convergence 2020

Keywords: Computed tomography (CT), Osteoarthritis, pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2020

Title: Osteoarthritis – Clinical Poster I

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Intra-articular (i.a.) calcium crystal deposition is common in knee osteoarthritis (OA). Low-grade inflammation related to crystals may contribute to knee pain, including pain fluctuation. Chondrocalcinosis has been measured primarily on radiographs to date, which have low sensitivity. We used CT to identify i.a. mineralization to overcome this limitation, and used longitudinal data to examine the relation of i.a. mineralization to the development of knee pain.

Methods: We used data from the Multicenter Osteoarthritis (MOST) Study, a NIH-funded longitudinal cohort of people with or at risk of knee OA. The 12th-year visit was the baseline for this analysis as this was the first study visit at which CTs were obtained, and a new cohort was recruited (age 45-69) who had KL ≤2 in both knees, and either no knee pain or if they had knee pain, it could not be severe, constant pain. All participants had pain questionnaires, knee radiographs, and bilateral knee CTs at baseline, and assessed for pain outcomes every 8 months x3. A musculoskeletal radiologist scored multiplanar CT images (axial native images with coronal and sagittal 2D reformats) using the Boston University Calcium Knee Score (BUCKS). Mineralization in each of WORMS-defined subregions of cartilage and menisci was scored on a 0-3 scale. Ligament and joint capsule mineralization were scored as present or absent. We examined presence of any i.a. mineralization, any cartilage mineralization, and any meniscal mineralization to the risk of development of: frequent knee pain (FKP) among those free of FKP at baseline, development of more frequent intermittent knee pain (indicated as at least “often”) or constant pain among those with no constant pain or only infrequent intermittent pain (occurring no more than “sometimes” based on the ICOAP) at baseline, and WOMAC worsening of ≥2/20 (MCID) over 2 years.  We carried out knee-specific analyses using logistic regression with GEE and adjusting for age, sex, BMI, race, and KL grade.

Results: A total of 2090 participants were included (mean age 61, mean BMI 28.8, 57% female). Overall, 10.2% of knees had i.a. mineralization, 7.3% had any cartilage, and 8.2% had meniscal mineralization. Presence of i.a. mineralization in a greater number of regions was associated with risk of developing FKP (OR 1.95, 95% CI 1.12-3.40), more frequent intermittent or constant pain (OR 1.97 (95% CI 1.06-3.66), and a trend towards more severe pain (OR 1.54, 95% CI 0.99-2.40) (Table). In addition, cartilage mineralization was significantly associated with developing more frequent intermittent and constant pain as well as developing more severe knee pain, while the association of meniscal mineralization with these pain outcomes did not reach statistical significance, though there were trends towards increased risk.

Conclusion: Intra-articular mineralization was associated with risk of developing knee pain and worsening pain over two years. This first report of CT-based i.a. mineralization on risk of knee pain highlights the important role crystals play in the knee pain experience. These findings implicate crystal deposition in changing pain patterns over time in knee OA, and point to need for research at therapy directed towards crystal disease in OA.

Relation of Intra-Articular Mineralization to Risk of Developing Knee Pain or Knee Pain Worsening Over Two Years


Disclosure: T. Neogi, Lilly, 1, EMD Merck Serono, 1, Novartis, 1, Regeneron, 1, Pfizer/Lilly, 1; J. Lynch, None; M. Jarraya, None; D. Felson, None; N. Wang, None; J. Torner, None; C. Lewis, None; M. Nevitt, None; A. Guermazi, AstraZeneca, 1, Pfizer, 1, MerckSerono, 1, Galapagos, 1, Roche, 1, TissueGene, 1, Boston Imaging Core Lab, 1.

To cite this abstract in AMA style:

Neogi T, Lynch J, Jarraya M, Felson D, Wang N, Torner J, Lewis C, Nevitt M, Guermazi A. Intra-Articular Mineralization on Knee CT Increases Risk of Knee Pain: The Multicenter Osteoarthritis Study [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/intra-articular-mineralization-on-knee-ct-increases-risk-of-knee-pain-the-multicenter-osteoarthritis-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/intra-articular-mineralization-on-knee-ct-increases-risk-of-knee-pain-the-multicenter-osteoarthritis-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology